Status:
NOT_YET_RECRUITING
Enhanced Pain Relief With Ultrasound Guided Combined Submaltifidus and Sacroiliac Joint Injection
Lead Sponsor:
Tanta University
Collaborating Sponsors:
Mohamed Shebl Abdelghany
Conditions:
Pain Management
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Sacroiliitis is not the same as SI joint dysfunction. Sacroiliitis is specific to an inflammatory processes present in the SI joint and the pain sensed is a direct result of those inflammatory process...
Detailed Description
Treatment of SI joint pain usually involves a multi-pronged approach, utilizing both, multi-modal medical pain control and interventional pain/surgical techniques such as local anesthetic and steroid ...
Eligibility Criteria
Inclusion
- patients aged above 21 years, both genders diagnosed with chronic sacroiliac joint pain with a rating on the numeric pain rating scale (NPRS) of at least 5, without radiculopathy lasting 3 months or longer, and lack of medical treatment satisfactory response
Exclusion
- Patient refusal. Patients who have any allergies to local anesthetics or have had a reaction to contrast dyes in the past.
- Patients who are unable to describe their pain (e.g., language barrier or neuropsychiatric disorder).
- Patients with history of bleeding diathesis
Key Trial Info
Start Date :
August 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT07137806
Start Date
August 20 2025
End Date
March 30 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Egypt